These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 17265808)
1. [Antiplatelet drugs and intraoperative hemorrhage]. Chassot PG; Delabays A; Ravussin P; Spahn DR Rev Med Suisse; 2006 Nov; 2(88):2684-7. PubMed ID: 17265808 [TBL] [Abstract][Full Text] [Related]
2. Antiplatelet medications and their indications in preventing and treating coronary thrombosis. Van De Graaff E; Steinhubl SR Ann Med; 2000 Nov; 32(8):561-71. PubMed ID: 11127934 [TBL] [Abstract][Full Text] [Related]
4. Antiplatelet agents in cardiology: the choice of therapy. Steinhubl SR Ann Thorac Surg; 2000 Aug; 70(2 Suppl):S3-8. PubMed ID: 10966004 [TBL] [Abstract][Full Text] [Related]
5. Dual antiplatelet therapy for coronary stenting: a clear path for a research agenda. Leopold JA; Antman EM Circulation; 2005 Mar; 111(9):1097-9. PubMed ID: 15753225 [No Abstract] [Full Text] [Related]
6. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809 [TBL] [Abstract][Full Text] [Related]
7. Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study. Cuisset T; Frere C; Quilici J; Morange PE; Mouret JP; Bali L; Moro PJ; Lambert M; Alessi MC; Bonnet JL JACC Cardiovasc Interv; 2008 Dec; 1(6):649-53. PubMed ID: 19463379 [TBL] [Abstract][Full Text] [Related]
8. [Antiplatelet therapy during coronary endoprosthesis placement]. Barragan P; Pietri P; Villain P; Silvestri M; Roquebert PO Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1515-20. PubMed ID: 9092412 [TBL] [Abstract][Full Text] [Related]
9. Current antiplatelet therapies: benefits and limitations. Angiolillo DJ; Guzman LA; Bass TA Am Heart J; 2008 Aug; 156(2 Suppl):S3-9. PubMed ID: 18657680 [TBL] [Abstract][Full Text] [Related]
10. Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study. Gurbel PA; Bliden KP; Zaman KA; Yoho JA; Hayes KM; Tantry US Circulation; 2005 Mar; 111(9):1153-9. PubMed ID: 15738352 [TBL] [Abstract][Full Text] [Related]
13. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should not be continued for more than 1 year and preferably indefinitely. Colombo A; Gerber RT Circ Cardiovasc Interv; 2008 Dec; 1(3):226-32. PubMed ID: 20031682 [No Abstract] [Full Text] [Related]
14. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. de Carvalho HC Rev Port Cardiol; 1999 Jun; 18(6):657-8. PubMed ID: 10422464 [No Abstract] [Full Text] [Related]
15. Antiplatelet therapy for ischemic heart disease. Lange RA; Hillis LD N Engl J Med; 2004 Jan; 350(3):277-80. PubMed ID: 14724308 [No Abstract] [Full Text] [Related]
16. Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY). Rangé G; Yayehd K; Belle L; Thuaire C; Richard P; Cazaux P; Barbou F; Köning R; Chassaing S; Teiger E; Berthier R; Decomis MP; Claudel JP; Delarche N; Brunel P; De Poli F; Dupouy P; Beygui F; Albert F; Collet JP; Montalescot G; Arch Cardiovasc Dis; 2014 Apr; 107(4):225-35. PubMed ID: 24794216 [TBL] [Abstract][Full Text] [Related]
17. [The most important aspects of risk assessment]. Wilhelm TJ; Post S Zentralbl Chir; 2013 Jun; 138(3):219-21. PubMed ID: 23967446 [No Abstract] [Full Text] [Related]
18. Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis. Claeys MJ; Van der Planken MG; Bosmans JM; Michiels JJ; Vertessen F; Van Der Goten P; Wuyts FL; Vrints CJ Eur Heart J; 2005 Mar; 26(6):567-75. PubMed ID: 15618034 [TBL] [Abstract][Full Text] [Related]
19. Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events. Rinaldi MJ; Kirtane AJ; Piana RN; Caputo RP; Gordon PC; Lopez JJ; Dauerman HL; Ryan TJ; Kiernan FJ; Cutlip DE; Ho KK; Gibson CM; Murphy SA; Cohen DJ Am Heart J; 2008 Apr; 155(4):654-60. PubMed ID: 18371472 [TBL] [Abstract][Full Text] [Related]